Contract With Customer Liability Revenue Recognized
Eton Pharmaceuticals, Inc.·Products & Services·1 segment·Rolls up to Revenue recognized that was included in deferred income at the beginning of the period
Breakdown
Segments
IncrelexView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Increlex | $80.5K | $80.5K | $80.5K | $80.5K | $158K |
| Total | — | — | — | — | — |